AGP Picks
View all

Hormonal Intrauterine Devices (IUDs) Market Analysis Highlights Growth To $4.74 Billion By 2030 At 10.5% CAGR

The Business Research Company

The Business Research Company

The Business Research Company's Hormonal Intrauterine Devices (IUDs) Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, August 11, 2026 /EINPresswire.com/ -- "The market for hormonal intrauterine devices (IUDs) has witnessed impressive growth recently, driven by shifts in reproductive health awareness and contraceptive preferences. With increasing demand for effective, long-term birth control methods, this sector is poised for continued expansion. Let’s explore the current market size, key factors fueling growth, regional highlights, and emerging trends in the hormonal IUD landscape.

Steady Market Expansion in Hormonal Intrauterine Devices (IUDs)
The hormonal intrauterine devices market has grown rapidly in recent years, with its value projected to rise from $2.87 billion in 2025 to $3.18 billion in 2026. This represents a robust compound annual growth rate (CAGR) of 10.6%. The growth seen historically stems from heightened awareness of family planning options, the broadening of reproductive healthcare programs targeting women, greater preference for long-acting contraceptives, widespread availability of hormone-based devices, and backing by public health initiatives worldwide.

Download a free sample of the hormonal intrauterine devices (iuds) market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19091&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR

Future Growth Trajectory of Hormonal IUDs Market
Looking ahead, the hormonal IUD market is set for further rapid expansion, expected to reach $4.74 billion by 2030 with a CAGR of 10.5%. This surge is mainly driven by rising interest in non-surgical contraceptive methods, increased focus on managing menstrual health, wider accessibility in emerging economies, heightened investments in women’s health technologies, and ongoing innovations in hormone delivery systems. Key trends shaping this future include greater adoption of low-dose hormonal IUDs, growing demand for long-acting reversible contraceptives, preference for frameless device designs, expanded therapeutic uses of IUDs, and improved attention to patient comfort and safety.

Understanding Hormonal Intrauterine Devices and Their Function
Hormonal IUDs are small, T-shaped plastic devices inserted into the uterus that release progestin, a synthetic hormone. Their primary mechanism is to prevent pregnancy by thickening cervical mucus to block sperm, thinning the uterine lining to prevent embryo implantation, and sometimes suppressing ovulation. Besides contraception, these devices often reduce menstrual bleeding and cramps, and for some users, periods may cease altogether.

View the full hormonal intrauterine devices (iuds) market report:
https://www.thebusinessresearchcompany.com/report/hormonal-intrauterine-devices-iuds-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR

Rising Concerns Over Unintended Pregnancies Bolster Hormonal IUD Demand
A significant factor propelling the global hormonal intrauterine devices market is the increase in unwanted pregnancies. These are pregnancies that are unplanned or undesired at conception and may result from contraceptive failures, lack of access to birth control, improper use, or sexual violence. Limited availability of effective contraception elevates this risk by restricting reproductive choice. Hormonal IUDs are highly effective, with failure rates below 1%, offering long-term protection lasting between 3 to 7 years depending on the model. For example, in July 2025, the Society for Family Planning reported that abortions in the United States rose to 1.14 million in 2024, compared to 1.05 million in 2023. This trend highlights the ongoing challenge of unwanted pregnancies, which continues to drive demand for reliable contraceptive solutions like hormonal IUDs.

North America Leads While Asia-Pacific Shows Rapid Growth Potential
In terms of regional dominance, North America was the largest market for hormonal intrauterine devices in 2025. However, the Asia-Pacific region is forecasted to experience the fastest growth during the upcoming years. The hormonal IUD market report covers key regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive view of global market trends and opportunities.

What’s included in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company"

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

European Morning Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.